메뉴 건너뛰기
The Lancet Neurology
Volumn 13, Issue 4, 2014, Pages 344-346
Embolic stroke of undetermined source: A therapeutic target?
Author keywords

[No Author keywords available]
Indexed keywords

ANTICOAGULANT AGENT;
EID: 84896081959     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70043-2     Document Type: Note
Times cited : (6)
References (9)
  • 1
    • 1342288363 scopus 로고    scopus 로고
    • Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention
    • on behalf of the Oxford Vascular Study
    • Lovett JK, Coull A, Rothwell PM Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention. Neurology 2004, 62:569-574. on behalf of the Oxford Vascular Study.
    • (2004) Neurology , vol.62 , pp. 569-574
    • Lovett, J.K.1    Coull, A.2    Rothwell, P.M.3
  • 2
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86. Antithrombotic Trialists' Collaboration.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 3
    • 64349105221 scopus 로고    scopus 로고
    • Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
    • Amarenco P, Labreuche J Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009, 8:453-463.
    • (2009) Lancet Neurol , vol.8 , pp. 453-463
    • Amarenco, P.1    Labreuche, J.2
  • 4
    • 0242694033 scopus 로고    scopus 로고
    • Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review
    • Rashid P, Leonardi-Bee J, Bath P Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003, 34:2741-2748.
    • (2003) Stroke , vol.34 , pp. 2741-2748
    • Rashid, P.1    Leonardi-Bee, J.2    Bath, P.3
  • 5
    • 0037431768 scopus 로고    scopus 로고
    • Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis
    • for the Carotid Endarterectomy Trialists' Collaboration
    • Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003, 361:107-116. for the Carotid Endarterectomy Trialists' Collaboration.
    • (2003) Lancet , vol.361 , pp. 107-116
    • Rothwell, P.M.1    Eliasziw, M.2    Gutnikov, S.A.3
  • 6
    • 0037145826 scopus 로고    scopus 로고
    • Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis
    • Van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002, 288:2441-2448.
    • (2002) JAMA , vol.288 , pp. 2441-2448
    • Van Walraven, C.1    Hart, R.G.2    Singer, D.E.3
  • 7
    • 0031455701 scopus 로고    scopus 로고
    • A randomized trial of anticoagulants versus aspirin after cerebral ischaemia of presumed arterial origin
    • for the Stroke Prevention in Reversible Ischaemia Trial (SPIRIT) group
    • Algra A, Francke CL, Koehler PJJ A randomized trial of anticoagulants versus aspirin after cerebral ischaemia of presumed arterial origin. Ann Neurol 1997, 42:857-865. for the Stroke Prevention in Reversible Ischaemia Trial (SPIRIT) group.
    • (1997) Ann Neurol , vol.42 , pp. 857-865
    • Algra, A.1    Francke, C.L.2    Koehler, P.J.J.3
  • 8
    • 0032862352 scopus 로고    scopus 로고
    • Major bleeding during anticoagulation after cerebral ischaemia: patterns and risk factors
    • for the Stroke Prevention in Reversible Ischaemia Trial (SPIRIT), European Atrial Fibrillation Trial (EAFT) groupsEuropean Atrial Fibrillation Trial (EAFT) groups
    • Gorter JW Major bleeding during anticoagulation after cerebral ischaemia: patterns and risk factors. Neurology 1999, 53:1319-1327. for the Stroke Prevention in Reversible Ischaemia Trial (SPIRIT), European Atrial Fibrillation Trial (EAFT) groupsEuropean Atrial Fibrillation Trial (EAFT) groups.
    • (1999) Neurology , vol.53 , pp. 1319-1327
    • Gorter, J.W.1
  • 9
    • 84896079786 scopus 로고    scopus 로고
    • Embolic strokes of undetermined source: the case for a new clinical construct
    • for the Cryptogenic Stroke/ESUS International Working Group
    • Hart RG, Diener H-C, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014, 13:429-438. for the Cryptogenic Stroke/ESUS International Working Group.
    • (2014) Lancet Neurol , vol.13 , pp. 429-438
    • Hart, R.G.1    Diener, H.-C.2    Coutts, S.B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.